(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.13%) $0.928
(0.20%) $10.86
(-0.01%) $0.792
(-0.97%) $91.68
Live Chart Being Loaded With Signals
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture...
Stats | |
---|---|
Today's Volume | 12 466.00 |
Average Volume | 11 339.00 |
Market Cap | 0.00 |
EPS | $0.0271 ( 2022-01-30 ) |
Last Dividend | $0.656 ( 2021-03-12 ) |
Next Dividend | $0 ( N/A ) |
P/E | -6 265.00 |
ATR14 | $0 (0.00%) |
Avid Bioservices, Inc. Correlation
10 Most Positive Correlations | |
---|---|
RCON | 0.899 |
ARHS | 0.896 |
UBFO | 0.893 |
SRAX | 0.878 |
FSBW | 0.876 |
BCML | 0.876 |
CGBD | 0.874 |
CVLY | 0.872 |
KBWB | 0.87 |
EWBC | 0.87 |
10 Most Negative Correlations | |
---|---|
CNST | -0.888 |
ANGI | -0.883 |
EPZM | -0.877 |
DDOG | -0.872 |
LFVN | -0.861 |
LASR | -0.861 |
IOVA | -0.855 |
FLGT | -0.854 |
DMRC | -0.852 |
ANIP | -0.851 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Avid Bioservices, Inc. Financials
Annual | 2023 |
Revenue: | $149.27M |
Gross Profit: | $31.48M (21.09 %) |
EPS: | $0.0100 |
Q4 | 2023 |
Revenue: | $39.80M |
Gross Profit: | $8.39M (21.08 %) |
EPS: | $-0.00490 |
Q3 | 2023 |
Revenue: | $38.02M |
Gross Profit: | $9.83M (25.84 %) |
EPS: | $0.0100 |
Q2 | 2023 |
Revenue: | $34.76M |
Gross Profit: | $4.15M (11.93 %) |
EPS: | $-0.0186 |
Financial Reports:
No articles found.
Avid Bioservices, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.299 | 2014-03-19 |
Last Dividend | $0.656 | 2021-03-12 |
Next Dividend | $0 | N/A |
Payout Date | 2021-04-01 | |
Next Payout Date | N/A | |
# dividends | 29 | -- |
Total Paid Out | $18.67 | -- |
Avg. Dividend % Per Year | 1.06% | -- |
Score | 2.46 | -- |
Div. Sustainability Score | 1.706 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.814 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $2.62 | 14.70% |
2019 | $2.62 | 12.90% |
2020 | $2.62 | 11.10% |
2021 | $0.656 | 2.40% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0812 | 1.500 | -1.625 | -2.44 | [0 - 0.5] |
returnOnAssetsTTM | -0.0252 | 1.200 | -0.839 | -1.007 | [0 - 0.3] |
returnOnEquityTTM | -0.0611 | 1.500 | -1.790 | -2.69 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.354 | 0.800 | 8.23 | 6.58 | [1 - 3] |
quickRatioTTM | 0.723 | 0.800 | -0.451 | -0.361 | [0.8 - 2.5] |
cashRatioTTM | 0.408 | 1.500 | 8.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.430 | -1.500 | 2.84 | -4.26 | [0 - 0.6] |
interestCoverageTTM | -8.05 | 1.000 | -4.09 | -4.09 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0270 | 2.00 | 9.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.886 | 2.00 | -0.443 | -0.886 | [0 - 20] |
debtEquityRatioTTM | 1.063 | -1.500 | 5.75 | -8.62 | [0 - 2.5] |
grossProfitMarginTTM | 0.125 | 1.000 | -1.246 | -1.246 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0805 | 1.000 | -3.61 | -3.61 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.00873 | 1.000 | -1.063 | -1.063 | [0.2 - 2] |
assetTurnoverTTM | 0.310 | 0.800 | -1.267 | -1.013 | [0.5 - 2] |
Total Score | 1.706 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -38.50 | 1.000 | -3.99 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0611 | 2.50 | -1.151 | -2.69 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.886 | 2.00 | -0.295 | -0.886 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0270 | 2.00 | 9.99 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.387 | 1.500 | -0.755 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0121 | 1.000 | -2.20 | 0 | [0.1 - 0.5] |
Total Score | -0.0787 |
Avid Bioservices, Inc.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators